Syndax Pharmaceuticals (SNDX) Stock: Buy, Sell, or Hold?
SNDX - Syndax Pharmaceuticals, Inc.
$13.09
0.19 (1.47%)
▲
5d:
-20.91%
30d:
-25.71%
90d:
-42.18%
WAIT
LOW Confidence
Analysis Updated: Oct 19, 2026 12:00 AM ET
Earnings: Nov 02, 2026
12d
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNDX is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SNDX is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $13.09, which is considered oversold relative to its 30-day fair value range of $15.26 to $18.78. From a valuation perspective, the stock is trading at a discount (Forward PE: -15.6) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong uptrend. The price is currently testing key support at $12.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNDX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.27 (+184.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNDX is in a strong uptrend. The price is currently testing key support at $12.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNDX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.27 (+184.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$15.26 -
$18.78
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
Holding SNDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 184.7% below Wall St target ($37.27)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$15.26 -
$18.78
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$18.19
Current Trend
Strong Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.60
Wall Street Target
$37.27
(+184.7%)
Revenue Growth (YoY)
91.8%
Profit Margin
-87.5%
PE vs Historical
-15.6 vs 126.3
CHEAP
Share & Embed Analysis
Last updated: October 20, 2026 5:57 AM ET
Data refreshes hourly during market hours. Next update: 6:57 AM
Data refreshes hourly during market hours. Next update: 6:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 55 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 44 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 58 HOLD |
|
STOK
Stoke Therapeutics Inc |
STRONG BUY
14 analysts |
$46 | 74 BUY |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 58 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
